BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
391 – 400 of 3081
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
- Contribution to journal › Article
-
Mark
Reliability test of measurements of lower limb volume and local tissue water in healthy subjects
- Contribution to journal › Published meeting abstract
-
Mark
Is there a role for immunomodulatory drugs in the treatment of mantle cell lymphoma?
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- Contribution to journal › Article
-
Mark
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re : Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961–7
- Contribution to journal › Letter
-
Mark
Clinical chemistry’s special issue on men’s health
- Contribution to journal › Debate/Note/Editorial
-
Mark
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
- Contribution to journal › Article
-
Mark
4D dosimetry and motion management in clinical radiotherapy
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
- Contribution to journal › Scientific review
-
Mark
Acoustic patterning of concentration fields and its real-time imaging
(2019) Acoustofluidics 2019
- Contribution to conference › Other
